Home » Stocks » SurModics

SurModics, Inc. (SRDX)

Stock Price: $47.74 USD 0.45 (0.95%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed
After-hours: $47.68 -0.06 (-0.13%) Aug 7, 4:18 PM

Stock Price Chart

Key Info

Market Cap 649.67M
Revenue (ttm) 103.14M
Net Income (ttm) 7.62M
Shares Out 13.65M
EPS (ttm) 0.56
PE Ratio 85.25
Forward PE 1,000.00
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $47.74
Previous Close $47.29
Change ($) 0.45
Change (%) 0.95%
Day's Open 46.99
Day's Range 46.45 - 48.49
Day's Volume 71,027
52-Week Range 22.06 - 49.00

More Stats

Market Cap 649.67M
Enterprise Value 589.10M
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 13.65M
Float 10.40M
EPS (basic) 0.57
EPS (diluted) 0.56
FCF / Share 1.52
Dividend n/a
Dividend Yield n/a
Earnings Yield 1.17%
FCF Yield 3.19%
Payout Ratio n/a
Shares Short 387,648
Short Ratio 5.05
Short % of Float 3.04%
Beta 0.97
PE Ratio 85.25
Forward PE 1,000.00
P/FCF Ratio 31.35
PS Ratio 6.30
PB Ratio 5.21
Revenue 103.14M
Operating Income 4.62M
Net Income 7.62M
Free Cash Flow 20.73M
Net Cash 60.56M
Net Cash / Share 4.45
Gross Margin 32.78%
Operating Margin 4.48%
Profit Margin 7.40%
FCF Margin 20.10%
ROA 2.07%
ROE 6.12%
ROIC 6.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(34.58% upside)
Current: $47.74
Target: 64.25
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth23.04%11.25%2.45%15.3%7.76%2.33%8.1%-1.57%-3.18%-
Gross Profit86.4467.3461.6960.4653.2849.4248.2344.5146.0147.68
Operating Income6.47-8.807.1016.8619.0918.5818.8216.3415.5211.99
Net Income7.59-4.463.939.9911.9512.0315.1710.23-18.51-21.09
Shares Outstanding13.3913.1613.1513.0013.0313.6314.4617.3217.4217.37
Earnings Per Share0.55-0.340.290.760.900.871.030.59-1.06-1.21
EPS Growth---61.84%-15.56%3.45%-15.53%74.58%---
Operating Cash Flow8.0434.0514.0525.1715.0218.1817.6716.1119.9622.01
Capital Expenditures-5.99-9.09-6.43-8.10-1.84-2.28-1.84-0.76-1.55-2.78
Free Cash Flow2.0524.967.6217.0613.1915.9115.8215.3518.4019.23
Cash & Equivalents55.2965.0248.3446.9455.5946.5525.7129.6638.4420.50
Net Cash / Debt55.2965.0248.3446.9455.5946.5525.7129.6638.4420.50
Book Value12310911210791.8798.7593.8294.99140154
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name SurModics, Inc.
Country United States
Employees 369
CEO Gary R. Maharaj

Stock Information

Ticker Symbol SRDX
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: SRDX
IPO Date March 4, 1998


Surmodics, Inc., together with its subsidiaries, provides medical devices and in vitro diagnostic technologies to the healthcare industry in the United States and internationally. The company operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment designs, develops, and manufactures interventional medical devices primarily for the peripheral vascular market; and offers surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device for the coronary, peripheral, neuro-vascular, urology, and other markets. The Vitro Diagnostics segment provides stabilization products, substrates, antigens, and surface coatings to diagnostics customers; and manufactures or sells components for in vitro diagnostic immunoassay and molecular tests, as well as surface coatings to the diagnostic, biomedical research, and life science markets. Surmodics, Inc. was founded in 1979 and is headquartered in Eden Prairie, Minnesota.